News

The big impacts of VIB’s highly cited papers: 2012-2017 analysis
25 June 2018
When VIB started out, about 4% of the papers written by our scientists achieved the highly cited label. Twenty years later, the proportion of VIB’s highly cited papers has more than doubled, reaching 10% in recent years.
Stronger together at Dystonia Europe’s D-Days
22 June 2018
Celebrating its 25-year existence, Dystonia Europe organized D-Days in Brussels on April 12 - 14. The event united patients living with dystonia – a rare neurological disease affecting about 10,000 Belgians – with doctors, researchers and policymakers.
EU-LIFE urges the European Parliament and the EU Council to push for a strong Horizon Europe
19 June 2018
EU-LIFE, the alliance of 13 leading life science research institutes in Europe, announced its reaction to the European Commission´s proposal for Horizon Europe, the next Framework Programme for Research and Innovation that will run from 2021 to 2027.
Basic science and business: how big is the gap?
18 June 2018
Basic science and business are actually the two sides of the same coin. This is especially true at VIB, an institute with a strong focus on the translational value of research
20 years of value creation
18 June 2018
Both drivers – curiosity and business potential – are imperative to conducting leading-edge science with long-term societal impacts
Starting a new biotech venture: embarking on a long-term adventure
18 June 2018
“Our job? Working together with world class scientists, seasoned managers and blue chip investors to bring value to society.” This is how our New Ventures team clears the path for the key ingredients of a successful VIB spin-off.
Pioneer or PhD: The spin-off success story of Luc Maertens
18 June 2018
Luc Maertens, currently CEO of agro-biotech firm AgroSavfe, followed Thierry Bogaert to Devgen and became a pioneer in turning disruptive technologies into innovative products and bringing them to the market.
Geert Noels: "unlock flanders’ biotech potential by investing in the very young"
18 June 2018
What if … VIB hadn’t been founded more than 20 years ago? According to economist and author Geert Noels, the answer is simple: we probably wouldn’t have the thriving biotech ecosystem we know today. But that’s no reason to rest on our laurels.
The building blocks of Cutting-edge biotech: how infrastructure drives VIB researchers and entrepreneurs forward
18 June 2018
Access to adequate infrastructure plays a crucial part in VIB’s impact and stature. In recent years, modern facilities that are fully-equipped for top-notch science have allowed our researchers to advance their fields with international acclaim.
Human and artificial intelligence join forces to study complexity of the brain
14 June 2018
A team of scientists lead by Stein Aerts (VIB-KU Leuven) is the first to map the gene expression of each individual brain cell during aging, though they started small: with the brain of a fruit fly.
Gene editing just got easier
8 June 2018
Toon Swings and Jan Michiels (VIB-KU Leuven) together with David Marciano (Baylor College of Medicine) and an international team of researchers have made CRISPR technology more accessible and standardized by simplifying its complex implementation.
Sleep problems in Parkinson’s disease: can we fix them?
7 June 2018
A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson’s disease suffer from sleep disturbances.
Working in a VIB start-up
7 June 2018
“It has always been a great experience to bring fundamental research results into practice through a spin-off company."
Unlocking the genome
4 June 2018
A team led by Stein Aerts (VIB-KU Leuven) uncovers how access to relevant DNA regions is orchestrated in epithelial cells. These findings shed new light on biological mechanisms of gene regulation & open up potential new avenues for cellular reprogramming
How did human brains get so large?
31 May 2018
The human brain is a remarkable organ, but how did it evolve to give us such unprecedented cognitive abilities? The research team of Pierre Vanderhaeghen (ULB, VIB-KU Leuven) turned to the genome for answers.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS